The National Agency for Food and Drug Administration and Control has reaffirmed its commitment to ensuring the quality, safety, and efficacy of generic medicines in Nigeria by enforcing stringent bioequivalence studies. Speaking on Thursday in Lagos, the Director General, NAFDAC, Prof. Moji Adeyeye, said the initiative, aimed at boosting public confidence in generic drugs, seeks
NAFDAC’s new regulations promise safer, reliable drugs
- Advertisement -
